|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 377.18 DKK | -1.60% |
|
+3.58% | +16.68% |
| 05:55pm | Boring No More |  |
| 01:08pm | Novo Nordisk Ready for Major Acquisitions in Obesity Sector, Says CEO - BN | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 265B | |||||
| 964B | |||||
| 515B | |||||
| 390B | |||||
| 363B | |||||
| 292B |
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition